Search results
Tapinarof may mark Dermavant’s first atopic dermatitis approval
Clinical Trials Arena via Yahoo Finance· 5 days agoTapinarof is an aryl hydrocarbon receptor (AhR) receptor modulator that has been observed to have...
Hongkongers told to safeguard against ‘flesh-eating’ bacteria when in Japan
South China Morning Post· 1 day agoAn infection of the “flesh-eating” bacteria Streptococcus pyogenes, or Group A streptococcus, can...
Reviva Pharmaceuticals (NASDAQ:RVPH) Price Target Cut to $14.00
ETF DAILY NEWS· 6 days agoReviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) had its target price cut by HC Wainwright from $20.00 to $14.00 in a research note issued on Tuesday, Benzinga reports. The firm presently ...
Roflumilast cream shows promise for long-term AD control By Investing.com
Investing.com· 7 days ago(NASDAQ:ARQT), a commercial-stage biopharmaceutical company, announced new study results today for...
To Heal Skin, Scientists Invent Living Bioelectron | Newswise
Newswise· 6 days agoFor much of his childhood, Simiao Niu was troubled by psoriasis, a chronic, often painful skin...
Gerber LLC Makes New $342,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 9 hours agoGerber LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
What's in a Name: Defining Difficult-to-Treat axSpA and PsA
Medscape· 4 days agoDespite an expanding arsenal of disease-modifying antirheumatic drugs (DMARDs), many patients with...
Health Benefits of Sarsaparilla
Health via Yahoo News· 6 days agoKeratinocytes are in the epidermis (the outermost layer of the skin). Therefore, astilbin may support the treatment of psoriasis because psoriasis ...
Infusions for psoriatic arthritis: Purpose, medications, benefits
Medical News Today· 5 days agoInfusion therapy for psoriatic arthritis (PsA) involves administering medications known as biologics...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Buy Rating from HC Wainwright
ETF DAILY NEWS· 6 days agoMoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research note issued on Tuesday, Benzinga reports ...
